A Prospective, Multi-national, Multi-center, Double-blind, Randomized, Active Controlled, Parallel-group, Seamless Phase II/III Clinical Study to Evaluate the Safety and Immunogenicity of 'LBVC (Sabin Poliomyelitis Vaccine (Inactivated))' Compared With 'Imovax® Polio (Poliomyelitis Vaccine (Inactivated))' in Healthy Infants
Phase of Trial: Phase II/III
Latest Information Update: 04 Sep 2019
Price : $35 *
At a glance
- Drugs Poliovirus vaccine inactivated (Primary)
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors LG Chem; LG Life Sciences
- 27 Aug 2019 Status changed from active, no longer recruiting to completed.
- 15 Jan 2019 Planned End Date changed from 31 May 2019 to 30 Jun 2019.
- 15 Jan 2019 Planned primary completion date changed from 31 Dec 2018 to 31 Jan 2019.